Table 1 –
Subject | Gender | Age | UPDRS-III Off | H & Y Stage | Dominant Hand | Dominant vs Test Hand Congruence | EC Trial Count, n | EC RT, seconds, mean | IC Trial Count, n | IC RT, seconds, mean | EC vs IC RT, t-test, P-Val |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | F | 57 | 14 | 2 | R | No | 25 | 0.52 | 24 | 0.61 | 0.01 |
2 | M | 71 | 21 | 2.5 | R | Yes | 49 | 0.51 | 50 | 0.62 | <0.01 |
3 | M | 68 | 32 | 2.5 | L | Yes | 25 | 0.59 | 22 | 0.63 | 0.23 |
4 | F | 52 | 25 | 2 | R | No | 44 | 0.55 | 48 | 0.59 | 0.15 |
5 | M | 57 | 22 | 3 | R | No | 25 | 0.78 | 23 | 0.82 | 0.37 |
6 | M | 59 | 28 | 1.5 | R | Yes | 52 | 0.67 | 51 | 0.72 | 0.11 |
7 | M | 57 | 29 | 2 | R | Yes | 51 | 0.49 | 50 | 0.48 | 0.80 |
8 | F | 60 | 49 | 2 | R | No | 50 | 0.74 | 49 | 0.74 | 0.93 |
9 | F | 61 | 44 | 3 | R | No | 18 | 0.88 | 17 | 1.13 | 0.01 |
10 | M | 67 | NA | 2 | R | Yes | 30 | 0.85 | 24 | 0.89 | 0.34 |
11 | F | 56 | 35 | 2 | L | No | 51 | 0.61 | 47 | 0.67 | 0.04 |
12 | M | 68 | 18 | 2 | R | No | 48 | 0.87 | 45 | 0.95 | 0.02 |
13 | M | 74 | 21 | 3 | L | Yes | 33 | 0.96 | 43 | 1.02 | 0.26 |
All Subjects, mean (SD) | - | 62.0 (6.7) | 28.1 (10.5) | 2.3 (0.50) | 38.5 (12.7) | 0.69 (0.16) | 37.9 (13.4) | 0.76 (0.19) | <0.01 |
EC, externally cued; H & Y, Hoehn and yahr Stage; IC, internally cued; L, left; n, number; NA, not available; RT, reaction time; UPDRS III Off, Part III of the Unified Parkinson’s Disease Rating Scale off-medications;
P <0.05, t-test